Rusfertide Treatment Beneficial for Patients With Polycythemia Vera; Rusfertide reduces number of phlebotomies and maintains hematocrit at less than 45 percent.

Media coverage

• Title	Rusfertide Treatment Beneficial for Patients With Polycythemia Vera; Rusfertide reduces number of phlebotomies and maintains hematocrit at less than 45 percent.
  Media name/outlet	Physician's Briefings
  Country/Territory	United States
  Date	22/02/24
  Persons	Marina Kremyanskaya